Passage Bio, Inc. PASG
3.46 USD +0.06 (+1.76%)
Nov 4, 2026, 3:26 PM EST
3.45 Day range 3.65
3.29 52-week range 20.00
- YTD
- -70.68%
- 1 year
- -47.89%
Financial health
Altman Z-Score
-43.91 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 2
Valuation
P/E -0.8×
FY 2018 5y median -0.6× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 2.0×
FY 2018 5y median 0.6× FY 2025
P/FCF -1.2×
FY 2018 5y median -0.7× FY 2025
EV/EBITDA -0.3×
FY 2018 5y median -0.5× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -84.2%
FY 2018 5y median -140.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -242.7%
FY 2018 5y median -91.7% FY 2025
ROIC -100.9%
FY 2018 5y median -72.8% FY 2025
ROA -73.1%
FY 2018 5y median -63.2% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 38.7%
FY 2018 FY 2025
EPS (diluted) 33.1%
FY 2018 FY 2025
Free Cash Flow 34.3%
FY 2018 FY 2025
Financial Health
Current Ratio 2.1×
FY 2018 5y median 7.2× FY 2025
Quick Ratio 2.1×
FY 2018 5y median 7.2× FY 2025
Debt / Equity 1.3×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 0.5×
FY 2018 5y median 0.2× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31